Viatris (VTRS) Depreciation & Amortization (CF) (2020 - 2026)

Viatris (VTRS) recorded quarterly Depreciation & Amortization (CF) of $676.1 million in Q1 2026, down 11.83% quarter-over-quarter from $766.8 million in Q4 2025, and up 1.72% on a YoY basis from $664.7 million in Q1 2025.

Viatris (VTRS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Viatris' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $676.1 million for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) rose 1.72% year-over-year to $676.1 million; the TTM figure through Mar 2026 stood at $2.8 billion (down 2.0% YoY), while the FY2025 annual figure was $2.8 billion, down 3.28% from the prior year.
  • Depreciation & Amortization (CF) was $676.1 million for Q1 2026 at Viatris, down from $766.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $869.8 million in Q4 2022 to a low of $644.4 million in Q4 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $713.9 million across 5 years, with a median of $691.0 million in 2024.
  • Biggest YoY gain for Depreciation & Amortization (CF) was 16.0% in 2022; the steepest drop was 48.26% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $869.8 million in 2022, then slipped by 25.91% to $644.4 million in 2023, then gained by 15.8% to $746.2 million in 2024, then gained by 2.76% to $766.8 million in 2025, then retreated by 11.83% to $676.1 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $676.1 million (Q1 2026), $766.8 million (Q4 2025), and $688.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 Viatris - - 1.16 Bn 676.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 676.10 Mn
Mar 31, 2026 676.10 Mn
Dec 31, 2025 766.80 Mn
Dec 31, 2025 766.80 Mn
Sep 30, 2025 688.50 Mn
Sep 30, 2025 688.50 Mn
Jun 30, 2025 678.30 Mn
Jun 30, 2025 678.30 Mn
Mar 31, 2025 664.70 Mn
Mar 31, 2025 664.70 Mn
Dec 31, 2024 746.20 Mn
Dec 31, 2024 746.20 Mn
Sep 30, 2024 669.70 Mn
Sep 30, 2024 669.70 Mn
Jun 30, 2024 786.30 Mn
Jun 30, 2024 786.30 Mn
Mar 31, 2024 691.00 Mn
Mar 31, 2024 691.00 Mn
Dec 31, 2023 644.40 Mn
Dec 31, 2023 644.40 Mn